aluates Reports

$ 0.0

Automative

Global Full-Service CDMO Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-2F17067

BUY CHAPTERS

Global Full-Service CDMO Market Research Report 2024

Code: QYRE-Auto-2F17067

Report

April 2024

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Company

Companies

PARTNERS

Lonza

Catalent

Thermo Fisher Scientific

Samsung Biologics

Fareva

WuXi AppTech

Wuxi Biologics

Siegfried

FUJIFILM Diosynth Biotechnologies

Asymchem

Pfizer CentreOne

Delpharm

Recipharm

AGC Pharma Chemicals

Boehringer Ingelheim

Vetter

Curia

Aenova

Porton

Piramal

Strides Pharma

NextPharma

Famar

Jubilant

Alcami

EUROAPI

Eurofins

Avid Bioservices

BioVectra

CPL

Full-Service CDMO Market

A Full-Service Contract Development and Manufacturing Organization (CDMO) is a company that provides comprehensive services across the entire drug development and manufacturing lifecycle, from early-stage development to commercial-scale production. These organizations offer a wide range of services to pharmaceutical and biotechnology companies, allowing them to outsource various aspects of drug development and manufacturing to external partners with specialized expertise and capabilities.

The global Full-Service CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Full-Service CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Full-Service CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Full-Service CDMO in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Full-Service CDMO include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Full-Service CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Full-Service CDMO.

The Full-Service CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Full-Service CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Full-Service CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Full-Service CDMO Market Report

Report Metric	Details
Report Name	Full-Service CDMO Market
Segment by Type	API CDMO FDF CDMO Packaging CDMO Clinical CDMO
Segment by Application	Pharmaceutical Company Biotechnology Company
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, Pfizer CentreOne, Delpharm, Recipharm, AGC Pharma Chemicals, Boehringer Ingelheim, Vetter, Curia, Aenova, Porton, Piramal, Strides Pharma, NextPharma, Famar, Jubilant, Alcami, Euroapi, Eurofins, Avid Bioservices, BioVectra, CPL
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Full-Service CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Full-Service CDMO Market report?

Ans: The main players in the Full-Service CDMO Market are Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, Pfizer CentreOne, Delpharm, Recipharm, AGC Pharma Chemicals, Boehringer Ingelheim, Vetter, Curia, Aenova, Porton, Piramal, Strides Pharma, NextPharma, Famar, Jubilant, Alcami, Euroapi, Eurofins, Avid Bioservices, BioVectra, CPL

What are the Application segmentation covered in the Full-Service CDMO Market report?

Ans: The Applications covered in the Full-Service CDMO Market report are Pharmaceutical Company, Biotechnology Company

What are the Type segmentation covered in the Full-Service CDMO Market report?

Ans: The Types covered in the Full-Service CDMO Market report are API CDMO, FDF CDMO, Packaging CDMO, Clinical CDMO

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Full-Service CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 API CDMO

1.2.3 FDF CDMO

1.2.4 Packaging CDMO

1.2.5 Clinical CDMO

1.3 Market by Application

1.3.1 Global Full-Service CDMO Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Full-Service CDMO Market Perspective (2019-2030)

2.2 Global Full-Service CDMO Growth Trends by Region

2.2.1 Global Full-Service CDMO Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Full-Service CDMO Historic Market Size by Region (2019-2024)

2.2.3 Full-Service CDMO Forecasted Market Size by Region (2025-2030)

2.3 Full-Service CDMO Market Dynamics

2.3.1 Full-Service CDMO Industry Trends

2.3.2 Full-Service CDMO Market Drivers

2.3.3 Full-Service CDMO Market Challenges

2.3.4 Full-Service CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Full-Service CDMO Players by Revenue

3.1.1 Global Top Full-Service CDMO Players by Revenue (2019-2024)

3.1.2 Global Full-Service CDMO Revenue Market Share by Players (2019-2024)

3.2 Global Full-Service CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Full-Service CDMO Revenue

3.4 Global Full-Service CDMO Market Concentration Ratio

3.4.1 Global Full-Service CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Full-Service CDMO Revenue in 2023

3.5 Global Key Players of Full-Service CDMO Head office and Area Served

3.6 Global Key Players of Full-Service CDMO, Product and Application

3.7 Global Key Players of Full-Service CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Full-Service CDMO Breakdown Data by Type

4.1 Global Full-Service CDMO Historic Market Size by Type (2019-2024)

4.2 Global Full-Service CDMO Forecasted Market Size by Type (2025-2030)

5 Full-Service CDMO Breakdown Data by Application

5.1 Global Full-Service CDMO Historic Market Size by Application (2019-2024)

5.2 Global Full-Service CDMO Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Full-Service CDMO Market Size (2019-2030)

6.2 North America Full-Service CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Full-Service CDMO Market Size by Country (2019-2024)

6.4 North America Full-Service CDMO Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Full-Service CDMO Market Size (2019-2030)

7.2 Europe Full-Service CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Full-Service CDMO Market Size by Country (2019-2024)

7.4 Europe Full-Service CDMO Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Full-Service CDMO Market Size (2019-2030)

8.2 Asia-Pacific Full-Service CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Full-Service CDMO Market Size by Region (2019-2024)

8.4 Asia-Pacific Full-Service CDMO Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Full-Service CDMO Market Size (2019-2030)

9.2 Latin America Full-Service CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Full-Service CDMO Market Size by Country (2019-2024)

9.4 Latin America Full-Service CDMO Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Full-Service CDMO Market Size (2019-2030)

10.2 Middle East & Africa Full-Service CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Full-Service CDMO Market Size by Country (2019-2024)

10.4 Middle East & Africa Full-Service CDMO Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza

11.1.1 Lonza Company Details

11.1.2 Lonza Business Overview

11.1.3 Lonza Full-Service CDMO Introduction

11.1.4 Lonza Revenue in Full-Service CDMO Business (2019-2024)

11.1.5 Lonza Recent Development

11.2 Catalent

11.2.1 Catalent Company Details

11.2.2 Catalent Business Overview

11.2.3 Catalent Full-Service CDMO Introduction

11.2.4 Catalent Revenue in Full-Service CDMO Business (2019-2024)

11.2.5 Catalent Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Full-Service CDMO Introduction

11.3.4 Thermo Fisher Scientific Revenue in Full-Service CDMO Business (2019-2024)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Samsung Biologics

11.4.1 Samsung Biologics Company Details

11.4.2 Samsung Biologics Business Overview

11.4.3 Samsung Biologics Full-Service CDMO Introduction

11.4.4 Samsung Biologics Revenue in Full-Service CDMO Business (2019-2024)

11.4.5 Samsung Biologics Recent Development

11.5 Fareva

11.5.1 Fareva Company Details

11.5.2 Fareva Business Overview

11.5.3 Fareva Full-Service CDMO Introduction

11.5.4 Fareva Revenue in Full-Service CDMO Business (2019-2024)

11.5.5 Fareva Recent Development

11.6 WuXi AppTech

11.6.1 WuXi AppTech Company Details

11.6.2 WuXi AppTech Business Overview

11.6.3 WuXi AppTech Full-Service CDMO Introduction

11.6.4 WuXi AppTech Revenue in Full-Service CDMO Business (2019-2024)

11.6.5 WuXi AppTech Recent Development

11.7 WuXi Biologics

11.7.1 WuXi Biologics Company Details

11.7.2 WuXi Biologics Business Overview

11.7.3 WuXi Biologics Full-Service CDMO Introduction

11.7.4 WuXi Biologics Revenue in Full-Service CDMO Business (2019-2024)

11.7.5 WuXi Biologics Recent Development

11.8 Siegfried

11.8.1 Siegfried Company Details

11.8.2 Siegfried Business Overview

11.8.3 Siegfried Full-Service CDMO Introduction

11.8.4 Siegfried Revenue in Full-Service CDMO Business (2019-2024)

11.8.5 Siegfried Recent Development

11.9 FUJIFILM Diosynth Biotechnologies

11.9.1 FUJIFILM Diosynth Biotechnologies Company Details

11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.9.3 FUJIFILM Diosynth Biotechnologies Full-Service CDMO Introduction

11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Full-Service CDMO Business (2019-2024)

11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.10 Asymchem

11.10.1 Asymchem Company Details

11.10.2 Asymchem Business Overview

11.10.3 Asymchem Full-Service CDMO Introduction

11.10.4 Asymchem Revenue in Full-Service CDMO Business (2019-2024)

11.10.5 Asymchem Recent Development

11.11 Pfizer CentreOne

11.11.1 Pfizer CentreOne Company Details

11.11.2 Pfizer CentreOne Business Overview

11.11.3 Pfizer CentreOne Full-Service CDMO Introduction

11.11.4 Pfizer CentreOne Revenue in Full-Service CDMO Business (2019-2024)

11.11.5 Pfizer CentreOne Recent Development

11.12 Delpharm

11.12.1 Delpharm Company Details

11.12.2 Delpharm Business Overview

11.12.3 Delpharm Full-Service CDMO Introduction

11.12.4 Delpharm Revenue in Full-Service CDMO Business (2019-2024)

11.12.5 Delpharm Recent Development

11.13 Recipharm

11.13.1 Recipharm Company Details

11.13.2 Recipharm Business Overview

11.13.3 Recipharm Full-Service CDMO Introduction

11.13.4 Recipharm Revenue in Full-Service CDMO Business (2019-2024)

11.13.5 Recipharm Recent Development

11.14 AGC Pharma Chemicals

11.14.1 AGC Pharma Chemicals Company Details

11.14.2 AGC Pharma Chemicals Business Overview

11.14.3 AGC Pharma Chemicals Full-Service CDMO Introduction

11.14.4 AGC Pharma Chemicals Revenue in Full-Service CDMO Business (2019-2024)

11.14.5 AGC Pharma Chemicals Recent Development

11.15 Boehringer Ingelheim

11.15.1 Boehringer Ingelheim Company Details

11.15.2 Boehringer Ingelheim Business Overview

11.15.3 Boehringer Ingelheim Full-Service CDMO Introduction

11.15.4 Boehringer Ingelheim Revenue in Full-Service CDMO Business (2019-2024)

11.15.5 Boehringer Ingelheim Recent Development

11.16 Vetter

11.16.1 Vetter Company Details

11.16.2 Vetter Business Overview

11.16.3 Vetter Full-Service CDMO Introduction

11.16.4 Vetter Revenue in Full-Service CDMO Business (2019-2024)

11.16.5 Vetter Recent Development

11.17 Curia

11.17.1 Curia Company Details

11.17.2 Curia Business Overview

11.17.3 Curia Full-Service CDMO Introduction

11.17.4 Curia Revenue in Full-Service CDMO Business (2019-2024)

11.17.5 Curia Recent Development

11.18 Aenova

11.18.1 Aenova Company Details

11.18.2 Aenova Business Overview

11.18.3 Aenova Full-Service CDMO Introduction

11.18.4 Aenova Revenue in Full-Service CDMO Business (2019-2024)

11.18.5 Aenova Recent Development

11.19 Porton

11.19.1 Porton Company Details

11.19.2 Porton Business Overview

11.19.3 Porton Full-Service CDMO Introduction

11.19.4 Porton Revenue in Full-Service CDMO Business (2019-2024)

11.19.5 Porton Recent Development

11.20 Piramal

11.20.1 Piramal Company Details

11.20.2 Piramal Business Overview

11.20.3 Piramal Full-Service CDMO Introduction

11.20.4 Piramal Revenue in Full-Service CDMO Business (2019-2024)

11.20.5 Piramal Recent Development

11.21 Strides Pharma

11.21.1 Strides Pharma Company Details

11.21.2 Strides Pharma Business Overview

11.21.3 Strides Pharma Full-Service CDMO Introduction

11.21.4 Strides Pharma Revenue in Full-Service CDMO Business (2019-2024)

11.21.5 Strides Pharma Recent Development

11.22 NextPharma

11.22.1 NextPharma Company Details

11.22.2 NextPharma Business Overview

11.22.3 NextPharma Full-Service CDMO Introduction

11.22.4 NextPharma Revenue in Full-Service CDMO Business (2019-2024)

11.22.5 NextPharma Recent Development

11.23 Famar

11.23.1 Famar Company Details

11.23.2 Famar Business Overview

11.23.3 Famar Full-Service CDMO Introduction

11.23.4 Famar Revenue in Full-Service CDMO Business (2019-2024)

11.23.5 Famar Recent Development

11.24 Jubilant

11.24.1 Jubilant Company Details

11.24.2 Jubilant Business Overview

11.24.3 Jubilant Full-Service CDMO Introduction

11.24.4 Jubilant Revenue in Full-Service CDMO Business (2019-2024)

11.24.5 Jubilant Recent Development

11.25 Alcami

11.25.1 Alcami Company Details

11.25.2 Alcami Business Overview

11.25.3 Alcami Full-Service CDMO Introduction

11.25.4 Alcami Revenue in Full-Service CDMO Business (2019-2024)

11.25.5 Alcami Recent Development

11.26 Euroapi

11.26.1 Euroapi Company Details

11.26.2 Euroapi Business Overview

11.26.3 Euroapi Full-Service CDMO Introduction

11.26.4 Euroapi Revenue in Full-Service CDMO Business (2019-2024)

11.26.5 Euroapi Recent Development

11.27 Eurofins

11.27.1 Eurofins Company Details

11.27.2 Eurofins Business Overview

11.27.3 Eurofins Full-Service CDMO Introduction

11.27.4 Eurofins Revenue in Full-Service CDMO Business (2019-2024)

11.27.5 Eurofins Recent Development

11.28 Avid Bioservices

11.28.1 Avid Bioservices Company Details

11.28.2 Avid Bioservices Business Overview

11.28.3 Avid Bioservices Full-Service CDMO Introduction

11.28.4 Avid Bioservices Revenue in Full-Service CDMO Business (2019-2024)

11.28.5 Avid Bioservices Recent Development

11.29 BioVectra

11.29.1 BioVectra Company Details

11.29.2 BioVectra Business Overview

11.29.3 BioVectra Full-Service CDMO Introduction

11.29.4 BioVectra Revenue in Full-Service CDMO Business (2019-2024)

11.29.5 BioVectra Recent Development

11.30 CPL

11.30.1 CPL Company Details

11.30.2 CPL Business Overview

11.30.3 CPL Full-Service CDMO Introduction

11.30.4 CPL Revenue in Full-Service CDMO Business (2019-2024)

11.30.5 CPL Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Company

Companies

PARTNERS

Lonza

Catalent

Thermo Fisher Scientific

Samsung Biologics

Fareva

WuXi AppTech

Wuxi Biologics

Siegfried

FUJIFILM Diosynth Biotechnologies

Asymchem

Pfizer CentreOne

Delpharm

Recipharm

AGC Pharma Chemicals

Boehringer Ingelheim

Vetter

Curia

Aenova

Porton

Piramal

Strides Pharma

NextPharma

Famar

Jubilant

Alcami

EUROAPI

Eurofins

Avid Bioservices

BioVectra

CPL

List of Tables

Table 1. Global Full-Service CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of API CDMO

Table 3. Key Players of FDF CDMO

Table 4. Key Players of Packaging CDMO

Table 5. Key Players of Clinical CDMO

Table 6. Global Full-Service CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Full-Service CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Full-Service CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Full-Service CDMO Market Share by Region (2019-2024)

Table 10. Global Full-Service CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Full-Service CDMO Market Share by Region (2025-2030)

Table 12. Full-Service CDMO Market Trends

Table 13. Full-Service CDMO Market Drivers

Table 14. Full-Service CDMO Market Challenges

Table 15. Full-Service CDMO Market Restraints

Table 16. Global Full-Service CDMO Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Full-Service CDMO Market Share by Players (2019-2024)

Table 18. Global Top Full-Service CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Full-Service CDMO as of 2023)

Table 19. Ranking of Global Top Full-Service CDMO Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Full-Service CDMO Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Full-Service CDMO, Headquarters and Area Served

Table 22. Global Key Players of Full-Service CDMO, Product and Application

Table 23. Global Key Players of Full-Service CDMO, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Full-Service CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Full-Service CDMO Revenue Market Share by Type (2019-2024)

Table 27. Global Full-Service CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Full-Service CDMO Revenue Market Share by Type (2025-2030)

Table 29. Global Full-Service CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Full-Service CDMO Revenue Market Share by Application (2019-2024)

Table 31. Global Full-Service CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Full-Service CDMO Revenue Market Share by Application (2025-2030)

Table 33. North America Full-Service CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Full-Service CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Full-Service CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Full-Service CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Full-Service CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Full-Service CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Full-Service CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Full-Service CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Full-Service CDMO Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Full-Service CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Full-Service CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Full-Service CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Full-Service CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Full-Service CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Full-Service CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 48. Lonza Company Details

Table 49. Lonza Business Overview

Table 50. Lonza Full-Service CDMO Product

Table 51. Lonza Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 52. Lonza Recent Development

Table 53. Catalent Company Details

Table 54. Catalent Business Overview

Table 55. Catalent Full-Service CDMO Product

Table 56. Catalent Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 57. Catalent Recent Development

Table 58. Thermo Fisher Scientific Company Details

Table 59. Thermo Fisher Scientific Business Overview

Table 60. Thermo Fisher Scientific Full-Service CDMO Product

Table 61. Thermo Fisher Scientific Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 62. Thermo Fisher Scientific Recent Development

Table 63. Samsung Biologics Company Details

Table 64. Samsung Biologics Business Overview

Table 65. Samsung Biologics Full-Service CDMO Product

Table 66. Samsung Biologics Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 67. Samsung Biologics Recent Development

Table 68. Fareva Company Details

Table 69. Fareva Business Overview

Table 70. Fareva Full-Service CDMO Product

Table 71. Fareva Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 72. Fareva Recent Development

Table 73. WuXi AppTech Company Details

Table 74. WuXi AppTech Business Overview

Table 75. WuXi AppTech Full-Service CDMO Product

Table 76. WuXi AppTech Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 77. WuXi AppTech Recent Development

Table 78. WuXi Biologics Company Details

Table 79. WuXi Biologics Business Overview

Table 80. WuXi Biologics Full-Service CDMO Product

Table 81. WuXi Biologics Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 82. WuXi Biologics Recent Development

Table 83. Siegfried Company Details

Table 84. Siegfried Business Overview

Table 85. Siegfried Full-Service CDMO Product

Table 86. Siegfried Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 87. Siegfried Recent Development

Table 88. FUJIFILM Diosynth Biotechnologies Company Details

Table 89. FUJIFILM Diosynth Biotechnologies Business Overview

Table 90. FUJIFILM Diosynth Biotechnologies Full-Service CDMO Product

Table 91. FUJIFILM Diosynth Biotechnologies Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 92. FUJIFILM Diosynth Biotechnologies Recent Development

Table 93. Asymchem Company Details

Table 94. Asymchem Business Overview

Table 95. Asymchem Full-Service CDMO Product

Table 96. Asymchem Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 97. Asymchem Recent Development

Table 98. Pfizer CentreOne Company Details

Table 99. Pfizer CentreOne Business Overview

Table 100. Pfizer CentreOne Full-Service CDMO Product

Table 101. Pfizer CentreOne Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 102. Pfizer CentreOne Recent Development

Table 103. Delpharm Company Details

Table 104. Delpharm Business Overview

Table 105. Delpharm Full-Service CDMO Product

Table 106. Delpharm Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 107. Delpharm Recent Development

Table 108. Recipharm Company Details

Table 109. Recipharm Business Overview

Table 110. Recipharm Full-Service CDMO Product

Table 111. Recipharm Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 112. Recipharm Recent Development

Table 113. AGC Pharma Chemicals Company Details

Table 114. AGC Pharma Chemicals Business Overview

Table 115. AGC Pharma Chemicals Full-Service CDMO Product

Table 116. AGC Pharma Chemicals Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 117. AGC Pharma Chemicals Recent Development

Table 118. Boehringer Ingelheim Company Details

Table 119. Boehringer Ingelheim Business Overview

Table 120. Boehringer Ingelheim Full-Service CDMO Product

Table 121. Boehringer Ingelheim Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 122. Boehringer Ingelheim Recent Development

Table 123. Vetter Company Details

Table 124. Vetter Business Overview

Table 125. Vetter Full-Service CDMO Product

Table 126. Vetter Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 127. Vetter Recent Development

Table 128. Curia Company Details

Table 129. Curia Business Overview

Table 130. Curia Full-Service CDMO Product

Table 131. Curia Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 132. Curia Recent Development

Table 133. Aenova Company Details

Table 134. Aenova Business Overview

Table 135. Aenova Full-Service CDMO Product

Table 136. Aenova Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 137. Aenova Recent Development

Table 138. Porton Company Details

Table 139. Porton Business Overview

Table 140. Porton Full-Service CDMO Product

Table 141. Porton Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 142. Porton Recent Development

Table 143. Piramal Company Details

Table 144. Piramal Business Overview

Table 145. Piramal Full-Service CDMO Product

Table 146. Piramal Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 147. Piramal Recent Development

Table 148. Strides Pharma Company Details

Table 149. Strides Pharma Business Overview

Table 150. Strides Pharma Full-Service CDMO Product

Table 151. Strides Pharma Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 152. Strides Pharma Recent Development

Table 153. NextPharma Company Details

Table 154. NextPharma Business Overview

Table 155. NextPharma Full-Service CDMO Product

Table 156. NextPharma Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 157. NextPharma Recent Development

Table 158. Famar Company Details

Table 159. Famar Business Overview

Table 160. Famar Full-Service CDMO Product

Table 161. Famar Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 162. Famar Recent Development

Table 163. Jubilant Company Details

Table 164. Jubilant Business Overview

Table 165. Jubilant Full-Service CDMO Product

Table 166. Jubilant Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 167. Jubilant Recent Development

Table 168. Alcami Company Details

Table 169. Alcami Business Overview

Table 170. Alcami Full-Service CDMO Product

Table 171. Alcami Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 172. Alcami Recent Development

Table 173. Euroapi Company Details

Table 174. Euroapi Business Overview

Table 175. Euroapi Full-Service CDMO Product

Table 176. Euroapi Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 177. Euroapi Recent Development

Table 178. Eurofins Company Details

Table 179. Eurofins Business Overview

Table 180. Eurofins Full-Service CDMO Product

Table 181. Eurofins Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 182. Eurofins Recent Development

Table 183. Avid Bioservices Company Details

Table 184. Avid Bioservices Business Overview

Table 185. Avid Bioservices Full-Service CDMO Product

Table 186. Avid Bioservices Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 187. Avid Bioservices Recent Development

Table 188. BioVectra Company Details

Table 189. BioVectra Business Overview

Table 190. BioVectra Full-Service CDMO Product

Table 191. BioVectra Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 192. BioVectra Recent Development

Table 193. CPL Company Details

Table 194. CPL Business Overview

Table 195. CPL Full-Service CDMO Product

Table 196. CPL Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 197. CPL Recent Development

Table 198. Research Programs/Design for This Report

Table 199. Key Data Information from Secondary Sources

Table 200. Key Data Information from Primary Sources

Table 201. Authors List of This Report

List of Figures

Figure 1. Full-Service CDMO Picture

Figure 2. Global Full-Service CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Full-Service CDMO Market Share by Type: 2023 VS 2030

Figure 4. API CDMO Features

Figure 5. FDF CDMO Features

Figure 6. Packaging CDMO Features

Figure 7. Clinical CDMO Features

Figure 8. Global Full-Service CDMO Market Size by Application (2024-2030) & (US$ Million)

Figure 9. Global Full-Service CDMO Market Share by Application: 2023 VS 2030

Figure 10. Pharmaceutical Company Case Studies

Figure 11. Biotechnology Company Case Studies

Figure 12. Full-Service CDMO Report Years Considered

Figure 13. Global Full-Service CDMO Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Full-Service CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Full-Service CDMO Market Share by Region: 2023 VS 2030

Figure 16. Global Full-Service CDMO Market Share by Players in 2023

Figure 17. Global Top Full-Service CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Full-Service CDMO as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Full-Service CDMO Revenue in 2023

Figure 19. North America Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Full-Service CDMO Market Share by Country (2019-2030)

Figure 21. United States Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Full-Service CDMO Market Share by Country (2019-2030)

Figure 25. Germany Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Full-Service CDMO Market Share by Region (2019-2030)

Figure 33. China Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Full-Service CDMO Market Share by Country (2019-2030)

Figure 41. Mexico Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Full-Service CDMO Market Share by Country (2019-2030)

Figure 45. Turkey Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Lonza Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 49. Catalent Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 51. Samsung Biologics Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 52. Fareva Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 53. WuXi AppTech Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 54. WuXi Biologics Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 55. Siegfried Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 57. Asymchem Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 58. Pfizer CentreOne Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 59. Delpharm Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 60. Recipharm Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 61. AGC Pharma Chemicals Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 62. Boehringer Ingelheim Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 63. Vetter Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 64. Curia Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 65. Aenova Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 66. Porton Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 67. Piramal Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 68. Strides Pharma Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 69. NextPharma Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 70. Famar Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 71. Jubilant Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 72. Alcami Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 73. Euroapi Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 74. Eurofins Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 75. Avid Bioservices Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 76. BioVectra Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 77. CPL Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 78. Bottom-up and Top-down Approaches for This Report

Figure 79. Data Triangulation

Figure 80. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025

Global Chemical CDMO Market Research Report 2024

Global Pharmaceutical CDMO Market Research Report 2025

Global Antibody Drug CDMO Service Market Research Report 2024

Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biopharmaceutical CDMO Service Market Research Report 2024

Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biopharmaceutical CDMO Market Research Report 2025

Global Small Molecule Drug CDMO Services Market Research Report 2024

Global Biopharmaceutical and Bio CDMO Market Research Report 2024

Pharmaceutical CDMO Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Formulation CDMO Services Market Research Report 2024

Global Bio Contract Development and Manufacturing Organizations CDMOs Market Insights Forecast to 2030

Global Oligonucleotide Drug CDMO Services Market Research Report 2024

Pharmaceutical CDMO Services Market

Global Cell and Gene Therapy CDMO Services Market Research Report 2024

Global Chemical Drug CDMO Market Research Report 2024

Global Small Molecules CDMO Services Market Research Report 2024

Global Large Molecule Drug Substance CDMO Market Research Report 2024

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions